Innovation for Life

Developing Innovative drugs, Biosimilars, Platforms, and Diagnostic technologies to improve lives.

Advancing Antibody Science

Advancing antibody drugs and biosimilars to address unmet medical needs.

Creating Value for a Healthier Life

Improving patient access through cost-effective, high-quality biosimilars.

PRESTIGE BIOPHARMA

PRESTIGE BIOPHARMA IDC

PRESTIGE BIOLOGICS

7

Beyond technological discovery, expanding access to care for patients around the world

Innovative Drug

Development of First-in-Class therapeutics for unmet diseases

Biosimilar

Prominent Biosimilars pipelines for accelerating market access

Platform Technology

A drug delivery platform that enhances treatment convenience

Diagnostics

Diagnostics for Pancreatic cancer by detecting PAUF

Prestige News

Total 70
Number Thumbnail Title Author Date Votes Views
60 Prestige Biopharma Outlines Phase 2a Clinical Development Roadmap for Pancreatic Cancer Therapy PBP1510
김** | 2026.06.01 | Votes 0 | Views 3056
김** 2026.06.01 0 3056
59 Prestige Biopharma Expands Global Collaboration Opportunities for Pancreatic Cancer Therapy at ASCO 2026
김** | 2026.05.26 | Votes 0 | Views 3430
김** 2026.05.26 0 3430
58 Prestige Biopharma IDC Signs Joint Research Agreement for Antibody Therapeutic Development Targeting Cancer Cachexia
김** | 2026.05.19 | Votes 0 | Views 2813
김** 2026.05.19 0 2813
57 Prestige BioPharma IDC Successfully Attracts Investment for Co-Development Partner
we******** | 2026.05.13 | Votes 0 | Views 1830
we******** 2026.05.13 0 1830
56 IDC Expands Asset Value to Over 200 Billion KRW… "Accelerating Commercialization on the Back of Financial Stability"
we******** | 2026.05.11 | Votes 0 | Views 1867
we******** 2026.05.11 0 1867
55 BJFEZ Expands ‘Insight Trip’ Program to High School Students: “Discovering the Future On-Site”
we******** | 2026.04.29 | Votes 0 | Views 1346
we******** 2026.04.29 0 1346
54 Prestige Biopharma IDC Files Patent for Next-Generation Antibody Delivery Platform ‘IDC224’
김** | 2026.04.21 | Votes 0 | Views 2107
김** 2026.04.21 0 2107
53 BJFEZ Advances Open Innovation Campus for AI-Driven Drug Development
김** | 2026.04.13 | Votes 0 | Views 1427
김** 2026.04.13 0 1427
52 Prestige Biopharma's Avastin Biosimilar HD204 Nears Regulatory Approval and Commercialization
김** | 2026.03.24 | Votes 0 | Views 3203
김** 2026.03.24 0 3203
51 Prestige Biopharma IDC Signs Strategic Research Collaboration Agreement with Pusan National University Medical Research Institu
김** | 2026.02.25 | Votes 0 | Views 1392
김** 2026.02.25 0 1392

Read Prestige news >>